Peps
Begin with the question the experiment could answer
Before reading the conclusion, find the population or model. A dish of tendon cells, an injured rat, and a person with cardiovascular disease are different research settings. Each can answer useful questions, but a result in one setting does not automatically answer a question in another.
BPC-157 research offers a concrete example. The 2003 Achilles paper measured tissue organization, mechanical properties, and function after a surgically created rat injury. Those outcomes are more informative than a generic claim that a peptide supports repair. They still do not tell a patient how quickly a human tendon injury would recover.
Separate an observed signal from an administered treatment
A substance naturally rising during exercise does not show that taking more of it reproduces exercise. In the 2021 MOTS-c paper, the human component measured changes in endogenous peptide levels. Peptide-administration experiments examining physical performance were performed in mice.
When a video describes that paper as human evidence, ask which component the speaker means. A mixed-model paper needs a mixed-model summary. The species, intervention, and outcome should travel together when the finding is repeated.
Read benefits and harms on the same page
In SELECT, cardiovascular events occurred in 6.5% of the semaglutide group and 8.0% of the placebo group over the reported follow-up. The absolute difference is 1.5 percentage points. The reported hazard ratio of 0.80 addresses relative event rates over time; it is a different description of the result.
Treatment discontinuation because of adverse events was also more frequent with semaglutide. A useful summary keeps that finding next to the benefit and identifies the trial population: people with established cardiovascular disease, overweight or obesity, and no diabetes history.
Source: Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes. ↗
Leave a trail another reader can follow
Save the paper identifier, year, exact preparation, population, comparator, endpoint, follow-up, and main limitation. If the summary comes from an abstract, say so. If a speaker did not identify a source, preserve that uncertainty instead of supplying a plausible paper as if it were confirmed.
PepsRadar’s evidence dashboard follows this structure. Its counts describe the selected publications summarized here; they are not a ranking of peptide quality or a count of every paper in the literature. Start with a profile, compare its study cards, and open the original publication before drawing a broader conclusion.
Continue with the original research
Study examples are based on selected publication abstracts and the explicitly described source documents. This is not a systematic review or an individualized treatment guide. Editorial scope and methods.